Geneva, April 28 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122377) titled 'Observational Study on the Treatment of Advanced Solid Tumors with heterogeneous onion periodical extended radiotherapy(HOPE-RT)Combined with PD-1 Monoclonal Antibody' on April 13.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Jiangsu Province Hospital of Chinese Medicine
Condition:
Solid tumors (including lung cancer, liver cancer, esophageal cancer, stomach cancer, nasopharyngeal cancer, urothelial carcinoma, and other MSI-H/dMMR solid tumors)
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-04-13
Target Sample Size: Observation group:49;
Coun...